{
    "title": "114_hr3284",
    "content": "The Act titled \"Mary Jo Lawyer Spano Mesothelioma Patient Registry Act of 2015\" establishes a patient registry for mesothelioma data collection and research under Title III of the Public Health Service Act. The Secretary will develop a patient registry to collect data on mesothelioma in the US, enhancing tracking of patients and reporting health information. The Secretary will use the registry to track mesothelioma patients, collect health information, describe incidence and prevalence in the US, and report treatment outcomes. The registry will track mesothelioma patients, collect health information, describe incidence and prevalence in the US, report treatment outcomes, and facilitate further research on mesothelioma. It aims to examine factors associated with mesothelioma and outline key demographic factors. The registry aims to track mesothelioma patients, collect health information, examine associated factors, outline key demographic factors, and make non-identifiable information available for research and prevention efforts. The Secretary will oversee the content of the registry. The registry will collect information on mesothelioma incidence and prevalence in the US, as well as other relevant data when possible, to support research and prevention efforts. The registry will collect information on mesothelioma incidence, prevalence, demographics, risk factors, and other relevant data in the US to support research and prevention efforts. The registry will collect demographics, risk factors, diagnosis markers, and epidemiology data related to mesothelioma for analysis and research purposes. The registry will collect information on environmental risk factors, diagnosis markers, epidemiology, prevention, detection, management, and treatment approaches for mesothelioma. The Secretary shall consult with experts on disease prevention, detection, management, treatment approaches, and outcomes measures for mesothelioma. The Secretary shall consult with non-Federal mesothelioma experts, including epidemiologists, representatives of national associations, health information technology experts, clinicians, and research scientists with experience in translational research or surveillance systems. The Secretary shall consult with non-Federal experts in mesothelioma research, care, health information technology, clinicians, and research scientists experienced in translational research or surveillance systems. Coordination with other federal agencies will involve sharing information and analysis from the registry with entities like the National Institutes of Health and the Food and Drug Administration. The Secretary will share information and analysis from the registry with federal agencies like the National Institutes of Health and the Food and Drug Administration. Public access to registry information will be provided by the Secretary. The Secretary will share registry information with federal agencies like the National Institutes of Health and the Food and Drug Administration, ensuring privacy and security protections are in place. Public access to registry data will also be provided. The Secretary will ensure stringent privacy and security protections for the registry, in line with HIPAA laws. Reports outlining findings in the mesothelioma registry will be submitted to Congress within 18 months of the Act's enactment. The Secretary will submit a report to Congress within 18 months of the Act's enactment, outlining findings in the mesothelioma patient registry, future expansion plans, and the registry's scope. The Secretary will report to Congress on the mesothelioma patient registry, including findings, future expansion plans, scope, and partnerships with research and patient advocacy communities. The Secretary will report to Congress on the development and maintenance of the mesothelioma patient registry, including partnerships with research and patient advocacy communities. The Secretary will submit a report to Congress on the implementation of the Patient Registry Act of 2015, including details on the development and maintenance of the mesothelioma patient registry, the type of information collected, its use and availability, and the coordination of databases for mesothelioma information."
}